Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity

BACKGROUND AND PURPOSE: The discovery of the pharmacological functions of nitric oxide has led to the development of NO donor compounds as therapeutic agents. A new generation of ruthenium NO donors, cis-[Ru(NO)(bpy)(2)L]X(n), has been developed, and our aim was to show that these complexes are able...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Silva, Jean Jerley Nogueira, Guedes, Paulo Marcos Matta, Zottis, Aderson, Balliano, Tatiane Luciano, Nascimento Silva, Francisco Ordelei, França Lopes, Luiz Gonzaga, Ellena, Javier, Oliva, Glaucius, Andricopulo, Adriano Defini, Franco, Douglas Wagner, Silva, João Santana
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2010
Assuntos:
Research Papers with Commentaries
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874849/
https://ncbi.nlm.nih.gov/pubmed/20105182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2009.00524.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares